Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study

• Päätekijät: Eugenia Oviedo-Joekes (Tekijä), Sophia Dobischok (Tekijä), José Carvajal (Tekijä), Scott MacDonald (Tekijä), Cheryl McDermid (Tekijä), Piotr Klakowicz (Tekijä), Scott Harrison (Tekijä), Julie LaJeunesse (Tekijä), Nancy Chow (Tekijä), Murray Brown (Tekijä), Sam Gill (Tekijä), Martin Schechter (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2023-05-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background To support public health measures during the COVID-19 pandemic, oral opioid agonist treatment (OAT) take-home doses were expanded in Western countries with positive results. Injectable OAT (iOAT) take-home doses were previously not an eligible option, and were made available for...